Update: Episurf Medical in the US Market
To support the Episealer Patellofemoral System, its first product in the region, Episurf is building a network of U.S. distributors....
Apr 11, 2023,
Update: Episurf Medical in the US Market
Bioventus Announces CEO Leadership Change
Ken Reali has stepped down as CEO and member of the Board of Directors. Anthony Bihl is appointed as interim...
Apr 06, 2023,
restor3d Gains FDA 510(k) for Patient Specific Resection Guides
The all metal resection guides incorporate an engineered surface to provide added stability between guide and bone....
Apr 06, 2023,
First U.S. Clinical Use of ZSFab Cervical Interbody System
Prior to this first US clinical use, the ZSFab Cervical Interbody System had already been successfully implanted in clinical cases...
Apr 06, 2023,
Osteopore Enters Research Collaboration
The project will study treatment of large post-traumatic bone defects using Osteopore’s custom Polycaprolactone and Tricalcium Phosphate implant. ...
Apr 06, 2023,
Ortho Development Partners with Naviswiss on Assistive Technology
The collaboration combines Ortho Development’s hip and knee replacement implants and Naviswiss’ miniaturized hand-held navigation solutions....
Apr 05, 2023,
Biologica Technologies Signs Agreements with Premier and Academy Medical
The partnerships increase the company's distribution footprint and provide new avenues to accelerate growth....
Apr 05, 2023,
Abyrx Gains Additional FDA Clearances for MONTAGE Bone Putty
MONTAGE settable, resorbable bone putty received additional 510(k) clearances as bone void filler and cranial bone cement....
Apr 05, 2023,
Multicenter Study of DEXA-C Cervical Interbody
Aurora Spine has received Independent Review Board multi-site selection approval for its DEXA-C Cervical Interbody System....
Apr 05, 2023,
Enovis to Buy Novastep from Amplitude Surgical
Novastep markets products for foot and ankle surgery, for instance Pecaplasty for bunion correction, the Centrolock guided transverse osteotomy system and...
Apr 03, 2023,
Loading new posts...
No more posts
